Crossmark

Analysis of PD-1/PD-L1 variations in lung cancer and association with immunotherapeutic efficacy and prognosis: A nonrandomized controlled trial

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2024.100395

Published Print: 2024-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ma, Jun https://orcid.org/0000-0002-2382-6687
Song, JianRui https://orcid.org/0009-0009-6899-9213
Han, LiNa https://orcid.org/0009-0005-1611-5341
Zhou, Wen https://orcid.org/0009-0004-8557-7139
Meng, LiFeng https://orcid.org/0009-0005-3849-8814
Li, JianHui https://orcid.org/0009-0001-9701-872X
Bai, XiaoMing https://orcid.org/0009-0004-0624-5938
License Information

Text and Data Mining valid from 2024-01-01

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2024-05-21
More Information

This article is maintained by: Elsevier

Article Title: Analysis of PD-1/PD-L1 variations in lung cancer and association with immunotherapeutic efficacy and prognosis: A nonrandomized controlled trial

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2024.100395

Content Type: article

Copyright: © 2024 HCFMUSP. Published by Elsevier España, S.L.U.